Medical Marijuana Market Size 2021
COVID 19- Update: Medical Marijuana Market Size was Estimated to be US$ 16.86 Bn in 2018 and is Expected grow at a CAGR of 20.55% Over the Forecast Period; says Absolute Markets Insights
Medical Marijuana Market Size Owing To the Increasing Demand for Marijuana-Based Medicines among End-Users as a Result of Economic Prices
The use of cannabis as a medicine has been a widely debated topic among the global audience. Though the unrestricted use of marijuana can have detrimental impacts on the immune and respiratory system, proponents of marijuana-derived medicines believe that synthesis of cannabis strain in non-lethal proportions can cure ailments such as arthritis, chronic and acute pain and loss of appetite, amongst others. It has been proved that the cannabis plant is infused with approximately 700 different types of chemicals. In this, the number of cannabinoids is around 100.
Access Full Report Details and Order this Premium Report @ https://www.absolutemarketsinsights.com/reports/Medical-Marijuana-Market-2019-2027-554
Major Key Players:
Some of the players operating in the Medical Marijuana Market Size are Abattis Bioceuticals Corp., Agripharm Corp., Aurora Cannabis Enterprises Inc.,Cannabis Sativa, Inc., CannaGrow Holdings, Inc., Canopy Growth Corporation, Cara Therapeutics, Inc, Cresco Labs, LLC, Emerald Health Botanicals Inc. , Growblox Sciences, Inc., GW Pharmaceuticals plc, Insys Therapeutics, Inc.. , Lexaria Corp., Medical Marijuana Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceuticals USA, Inc.,Tweed Inc.,United Cannabis Corporation and Whistler Medical Marijuana Corp, amongst others.
Key findings of the report:
Based on the application, pain management accounted for the highest share in global Medical Marijuana Market Size in 2018. The economic prices of marijuana medicines coupled with the reduced side effects is propelling this growth.
Based on distribution channels, pharmacies account for the highest share in the global Medical Marijuana Market Size. The ease of distribution through licensed pharmacies is a major reason for this.
As far as geography is concerned, North America accounted for maximum share in the global Medical Marijuana Market Size in 2018. This can be attributed to the liberal laws in Canada and several U.S. states and the presence of prominent marijuana producers with cutting edge technology in the region.
Market Segmentation
By Application
Pain Management
Neuropathic
Inflammatory
Neurological Health Management
Sclerosis
Epilepsy
Alzheimer’s Disease
Parkinson’s Disease
Huntington’s Disease
Other Diseases
Mental Health Management
Post Traumatic Stress Disorder (PTSD)
Depression
Anxiety
ADHD
Others
Others
By Distribution Channel
Pharmacies
Hospitals and Dispensaries
Online Retailers
By Type
Indica
Sativa
Hybrid
By Form
Capsule
Spray
Oil
Others
By Geography
North America
U.S
Canada
Mexico
Rest of North America
Europe
UK
Germany
Italy
Switzerland
Nordic Countries
Denmark
Finland
Norway
Benelux Union
Belgium
The Netherlands
Luxembourg
Rest of Europe
Asia Pacific
New Zealand
Australia
South Korea
Southeast Asia
Thailand
Malaysia
Rest of Southeast Asia
Rest of Asia Pacific
Middle East and Africa
Israel
Zimbabwe
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Uruguay
Rest of Latin America
Contact us:
Shreyas Tanna
Phone: +91-740-024-2424
Absolute Markets Insights
